CIAM
AMED

Caitong International Asset Management’s Amedisys AMED Stock Holding History

Caitong International Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-321
Closed -$31.6K – 1910
2025
Q2 		$31.6K Buy
+321
New +$30.4K 0.02% 383
2025
Q1 		– Sell
-28
Closed -$2.54K – 2143
2024
Q4 		$2.54K Buy
+28
New +$2.57K ﹤0.01% 1141

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caitong International Asset Management's AMED Position: Q3 2025 in Review

Caitong International Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 321 shares — an estimated $31.6K sold.

Caitong International Asset Management first reported a position in AMED in Q4 2024 and held it in 2 quarters. The position peaked at $31.6K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Caitong International Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 321 Amedisys shares in Q3 2025, an estimated $31.6K.
  • Caitong International Asset Management first reported a position in Amedisys in Q4 2024 and held it in 2 quarters.
  • Caitong International Asset Management's Amedisys position peaked at $31.6K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.